Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 146

1.

Women with cardiovascular disease have increased risk of osteoporotic fracture.

Chen JS, Hogan C, Lyubomirsky G, Sambrook PN.

Calcif Tissue Int. 2011 Jan;88(1):9-15. doi: 10.1007/s00223-010-9431-7. Epub 2010 Nov 4.

PMID:
21046091
2.

Primary care use of FRAX: absolute fracture risk assessment in postmenopausal women and older men.

Siris ES, Baim S, Nattiv A.

Postgrad Med. 2010 Jan;122(1):82-90. doi: 10.3810/pgm.2010.01.2102. Review.

PMID:
20107292
3.

Calcium and vitamin D intake influence bone mass, but not short-term fracture risk, in Caucasian postmenopausal women from the National Osteoporosis Risk Assessment (NORA) study.

Nieves JW, Barrett-Connor E, Siris ES, Zion M, Barlas S, Chen YT.

Osteoporos Int. 2008 May;19(5):673-9. Epub 2007 Nov 13.

PMID:
17999024
4.

Ankle fractures do not predict osteoporotic fractures in women with or without diabetes.

Pritchard JM, Giangregorio LM, Ioannidis G, Papaioannou A, Adachi JD, Leslie WD.

Osteoporos Int. 2012 Mar;23(3):957-62. doi: 10.1007/s00198-011-1648-4. Epub 2011 May 12.

PMID:
21562874
5.

Cardiovascular diseases and future risk of hip fracture in women.

Sennerby U, Farahmand B, Ahlbom A, Ljunghall S, Michaëlsson K.

Osteoporos Int. 2007 Oct;18(10):1355-62. Epub 2007 May 10.

PMID:
17492247
6.

Characterisation of patients with postmenopausal osteoporosis in French primary healthcare.

Blotman F, Cortet B, Hilliquin P, Avouac B, Allaert FA, Pouchain D, Gaudin AF, Cotté FE, El Hasnaoui A.

Drugs Aging. 2007;24(7):603-14.

PMID:
17658910
7.

Osteoporosis prevalence and levels of treatment in primary care: the Australian BoneCare Study.

Eisman J, Clapham S, Kehoe L; Australian BoneCare Study.

J Bone Miner Res. 2004 Dec;19(12):1969-75. Epub 2004 Sep 13.

8.
9.

Trends and determinants of antiresorptive drug use for osteoporosis among elderly women.

Perreault S, Dragomir A, Desgagné A, Blais L, Rossignol M, Blouin J, Moride Y, Ste-Marie LG, Fernandès JC.

Pharmacoepidemiol Drug Saf. 2005 Oct;14(10):685-95.

PMID:
15645517
10.

Independent predictors of all osteoporosis-related fractures in healthy postmenopausal women: the OFELY study.

Albrand G, Munoz F, Sornay-Rendu E, DuBoeuf F, Delmas PD.

Bone. 2003 Jan;32(1):78-85.

PMID:
12584039
11.

Strategies for the prevention and treatment of osteoporosis during early postmenopause.

Delaney MF.

Am J Obstet Gynecol. 2006 Feb;194(2 Suppl):S12-23. Review.

PMID:
16448872
12.

Case finding for the management of osteoporosis with FRAX--assessment and intervention thresholds for the UK.

Kanis JA, McCloskey EV, Johansson H, Strom O, Borgstrom F, Oden A; National Osteoporosis Guideline Group.

Osteoporos Int. 2008 Oct;19(10):1395-408. doi: 10.1007/s00198-008-0712-1. Epub 2008 Aug 28. Erratum in: Osteoporos Int. 2009 Mar;20(3):499-502.

PMID:
18751937
13.

High osteoporotic fracture risk and CVD risk co-exist in postmenopausal women.

Makovey J, Macara M, Chen JS, Hayward CS, March L, Sambrook PN.

Bone. 2013 Jan;52(1):120-5. doi: 10.1016/j.bone.2012.09.025. Epub 2012 Sep 27.

PMID:
23023015
14.

Dietary protein intake and risk of osteoporotic hip fracture in elderly residents of Utah.

Wengreen HJ, Munger RG, West NA, Cutler DR, Corcoran CD, Zhang J, Sassano NE.

J Bone Miner Res. 2004 Apr;19(4):537-45. Epub 2004 Feb 9.

15.

Low fractional calcium absorption increases the risk for hip fracture in women with low calcium intake. Study of Osteoporotic Fractures Research Group.

Ensrud KE, Duong T, Cauley JA, Heaney RP, Wolf RL, Harris E, Cummings SR.

Ann Intern Med. 2000 Mar 7;132(5):345-53.

PMID:
10691584
16.

Osteoporosis and cardiovascular disease: benefit-risk of hormone replacement therapy.

Sammartino A, Cirillo D, Mandato VD, Di Carlo C, Nappi C.

J Endocrinol Invest. 2005;28(10 Suppl):80-4. Review.

PMID:
16550729
17.

Prevalence of osteoporotic fracture risk factors and antiosteoporotic treatments in the Valencia region, Spain. The baseline characteristics of the ESOSVAL cohort.

Sanfélix-Genovés J, Sanfélix-Gimeno G, Peiró S, Hurtado I, Fluixà C, Fuertes A, Campos JC, Giner V, Baixauli C.

Osteoporos Int. 2013 Mar;24(3):1045-55. doi: 10.1007/s00198-012-2018-6. Epub 2012 May 23.

PMID:
22618269
18.

Comparison of fracture, cardiovascular event, and breast cancer rates at 3 years in postmenopausal women with osteoporosis.

Silverman SL, Delmas PD, Kulkarni PM, Stock JL, Wong M, Plouffe L Jr.

J Am Geriatr Soc. 2004 Sep;52(9):1543-8.

PMID:
15341559
19.

The application of FRAX® to determine intervention thresholds in osteoporosis treatment in Poland.

Badurski JE, Kanis JA, Johansson H, Dobreńko A, Nowak NA, Daniluk S, Jezienicka E.

Pol Arch Med Wewn. 2011 May;121(5):148-55.

20.

Parity and risk of hip fracture in postmenopausal women.

Kauppi M, Heliövaara M, Impivaara O, Knekt P, Jula A.

Osteoporos Int. 2011 Jun;22(6):1765-71. doi: 10.1007/s00198-010-1392-1. Epub 2010 Oct 6.

PMID:
20924749
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk